神经退行性疾病中的微生物特征和治疗策略
Mlaak Rob1, Mahmoud Yousef1, Arun Prasath Lakshmanan2
1Weill Cornell Medical College Qatar, Education city, P.O.Box 24144, Doha, Qatar.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|February 11, 2025
概括
肠道微生物组和代谢组的改变与神经退行性疾病 (NDs) 相关,如阿尔茨海默氏症和帕金森氏症. 通过饮食和治疗来调节肠道健康可能有助于管理NDs的进展和症状.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 代谢学 代谢学 代谢学
- 遗传学 是一个遗传学.
背景情况:
- 神经退行性疾病 (NDs) 是由遗传,环境和衰老因素造成的.
- 肠道失生症越来越多地被认为是其在全身炎症和神经退行症中的作用.
- 微生物组和代谢组概况为NDs的病原性提供了新的见解.
研究的目的:
- 在神经退行性疾病中审查肠道微生物群和代谢源生物标志物.
- 探索生活方式和治疗干预对NDs肠道微生物群的影响.
- 突出AI和ML在推进NDs个性化医学的作用.
主要方法:
- 对肠道微生物组和代谢组变化的研究进行系统审查.
- 对不同神经退行性疾病 (PD,AD,ALS,MS) 的微生物特征分析.
- 对诸如益生菌,益生菌,FMT,饮食,运动和睡眠等干预措施的评估.
主要成果:
- 在PD (55),AD (24),ALS (4) 和MS (17) 中确定了特定的微生物变化.
- 观察到PD,AD和MS中的Akkermansia增加,PD和AD中的短链脂肪酸 (SCFA) 减少.
- 诸如益生菌,饮食和运动等干预措施显示出延迟发病和缓解症状的潜力.
结论:
- 在神经退行性疾病中,肠道微生物组和代谢组生物标志物发生显著变化.
- 微生物群调节疗法和生活方式干预措施对管理NDs有希望.
- 人工智能和机器学习对于识别治疗点和使个人化医疗在NDS中成为可能至关重要.
相关概念视频
Alzheimer's Disease: Treatment
155
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
155
Alzheimer's Disease: Overview
432
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
432
Parkinson's Disease: Overview
436
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
436


